Literature DB >> 19606493

Temporal lobe changes in early, untreated Parkinson's disease.

W R Wayne Martin1, Marguerite Wieler, Myrlene Gee, Richard Camicioli.   

Abstract

The purpose of this study was to determine if focal cortical abnormalities may occur in early Parkinson's disease (PD). We studied 26 untreated patients with early PD and 14 healthy control subjects, with cognitive screening and magnetic resonance imaging (MRI). Voxel-based morphometry was used to assess for the presence of localized cortical grey matter (GM) and/or subcortical white matter (WM) changes. Patient and control groups showed no differences in age or gender distribution. Females had a greater GM% than males (P = 0.001). Comparison of patients and controls revealed no difference in local GM volumes. In PD, however, there was decreased WM volume in the anterior right fusiform gyrus and superior temporal gyrus. There were no correlations between the California Verbal Learning Test long delay free recall, Judgment of Line Orientation, Trail Making A or B and either the GM or WM localized volumes. These results suggest that right anterior temporal lobe changes occur in untreated patients with PD. The earliest changes may occur in subcortical white matter rather than temporal cortex.

Entities:  

Mesh:

Year:  2009        PMID: 19606493     DOI: 10.1002/mds.22680

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

Review 1.  Profile of cognitive impairment in Parkinson's disease.

Authors:  G Stennis Watson; James B Leverenz
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

2.  The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Authors:  Mechelle M Lewis; Guangwei Du; Eun-Young Lee; Zeinab Nasralah; Nicholas W Sterling; Lijun Zhang; Daymond Wagner; Lan Kong; Alexander I Tröster; Martin Styner; Paul J Eslinger; Richard B Mailman; Xuemei Huang
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

Review 3.  Differences between conventional and nonconventional MRI techniques in Parkinson's disease.

Authors:  A Baglieri; M A Marino; R Morabito; G Di Lorenzo; P Bramanti; S Marino
Journal:  Funct Neurol       Date:  2013 Apr-May

4.  Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease.

Authors:  Karthik Sreenivasan; Virendra Mishra; Christopher Bird; Xiaowei Zhuang; Zhengshi Yang; Dietmar Cordes; Ryan R Walsh
Journal:  Parkinsonism Relat Disord       Date:  2019-02-07       Impact factor: 4.891

Review 5.  Parkinson's disease as a disconnection syndrome.

Authors:  Alice Cronin-Golomb
Journal:  Neuropsychol Rev       Date:  2010-04-10       Impact factor: 7.444

6.  Considering total intracranial volume and other nuisance variables in brain voxel based morphometry in idiopathic PD.

Authors:  Samuel Crowley; Haiqing Huang; Jared Tanner; Qing Zhao; Nadine A Schwab; Loren Hizel; Daniel Ramon; Babette Brumback; Mingzhou Ding; Catherine C Price
Journal:  Brain Imaging Behav       Date:  2018-02       Impact factor: 3.978

7.  Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Authors:  Daniel Weintraub; Nicole Dietz; John E Duda; David A Wolk; Jimit Doshi; Sharon X Xie; Christos Davatzikos; Christopher M Clark; Andrew Siderowf
Journal:  Brain       Date:  2011-11-21       Impact factor: 13.501

8.  Neurodegeneration across stages of cognitive decline in Parkinson disease.

Authors:  Daniel Weintraub; Jimit Doshi; Deepthi Koka; Christos Davatzikos; Andrew D Siderowf; John E Duda; David A Wolk; Paul J Moberg; Sharon X Xie; Christopher M Clark
Journal:  Arch Neurol       Date:  2011-12

Review 9.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

10.  Whole-brain proton MR spectroscopic imaging in Parkinson's disease.

Authors:  Bonnie E Levin; Heather L Katzen; Andrew Maudsley; Judith Post; Connie Myerson; Varan Govind; Fatta Nahab; Blake Scanlon; Aaron Mittel
Journal:  J Neuroimaging       Date:  2012-12-10       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.